Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds

Cornelia Speth1, Magdalena Hagleitner, Helmut W Ott

  • 1Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria. cornelia.speth@i-med.ac.at

Insights

Platelets are activated by Aspergillus fumigatus, enhancing immune defense but potentially causing harm. This fungal activation of thrombocytes may serve as a diagnostic marker for invasive aspergillosis.

Area of Science:

  • Immunology
  • Hematology
  • Mycology

Background:

  • Invasive aspergillosis involves complex host-pathogen interactions.
  • The role of platelets (thrombocytes) in fungal infections is not fully understood.
  • Platelets may contribute to both defense and pathology during Aspergillus infections.

Purpose of the Study:

  • To investigate whether Aspergillus fumigatus secretes factors that influence platelet activity.
  • To determine the mechanisms and consequences of fungus-induced platelet activation.

Main Methods:

  • Platelets were incubated with Aspergillus fumigatus culture supernatant.
  • Platelet activation was assessed by measuring granule release, membrane changes, aggregation, and microparticle formation.
  • In vivo studies involved infecting mice with A. fumigatus and analyzing thrombocyte activation.
  • Stimulating components in the supernatant were identified.

Main Results:

  • Fungal culture supernatant potently stimulated platelets in a time- and dose-dependent manner.
  • Stimulation induced platelet degranulation, aggregation, and microparticle formation.
  • Infected mice exhibited higher platelet activation levels compared to controls.
  • A fungal serine protease and the mycotoxin gliotoxin were identified as key activators.
  • Activated platelets demonstrated enhanced antifungal activity, inhibiting fungal growth.

Conclusions:

  • Aspergillus fumigatus secretes factors that activate platelets, influencing their function.
  • Platelet activation by fungal components supports antifungal immunity but may also promote inflammation and thrombosis.
  • Platelet activation could be a potential diagnostic parameter for invasive aspergillosis.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...